Industry Commitment For Antibiotic Resistance Strategy

by | Apr 8, 2014 | News | 0 comments

In an update to the public last week, the FDA announced that all but one animal drug company have committed to seek withdrawal of approvals for any production uses of affected drug applications and change the remaining therapeutic uses of their products from over-the-counter to use by Veterinary Feed Directive or prescription. These changes stem from the implementation of FDA Guidance #213 that was announced in December of last year. The FDA is pleased with the strong responses received thus far and promises to continue to provide updates to the public. For the official announcement from the FDA, read here.

Recent GVL Blog Posts

Support Report from GVL Customer Success

Support Report from GVL Customer Success

Welcome to our monthly newsletter created by the Customer Success team to highlight seasonal trends, helpful hints, and GVL news. A view from our desks (at home) As expected, last month showed a decline in case volume due to COVID-19. With the decline in animal...

Your Simple Solution for Complicated International Pet Movement

Your Simple Solution for Complicated International Pet Movement

When it comes to traveling out of the US with pets, veterinarians are challenged with helping their clients understand the various requirements for the destination country. Each country has its own unique rules and regulations around animals, and it’s time consuming...

GVL Small Animal Industry Expert Brenda Flaming, DVM

GVL Small Animal Industry Expert Brenda Flaming, DVM

The GVL® Expert Council was created to better understand our customers’ needs by providing industry knowledge and expertise for product development. We are featuring our Expert Council members on our blog so you can learn more about their fields of research and the...